← All trials
NCT04629560
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 18, 2008
- Primary completion
- Jun 20, 2011
- Completion date
- Jun 20, 2011
- First posted
- Nov 16, 2020
- Last posted
- Nov 16, 2020
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Mt. Sinai Medical Center, MiamiLead sponsor
- Icahn School of Medicine at Mount SinaiStudy chair
- Mt. Sinai Medical Center, MiamiReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.